{"id":"W2140055441","doi":"10.1200/jco.2008.20.6847","title":"Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":850,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"F. Hoffmann-La Roche; Sanofi; AstraZeneca; Eli Lilly and Company","keywords":"Anastrozole; Medicine; Trastuzumab; Internal medicine; Metastatic breast cancer; Hazard ratio; Oncology; Breast cancer; Aromatase inhibitor; Gynecology; Cancer; Tamoxifen; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001839366,0.001006453,0.00200939,0.0003585457,0.0002018225,0.00074298,0.0005698139,0.0009476272,0.002567432],"category_scores_gemma":[0.001622093,0.0004503379,0.001611602,0.0003255128,0.0006189022,0.0007335606,0.0002727703,0.001845297,0.0004412104],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006921702,"about_ca_system_score_gemma":0.0009386999,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006622195,"about_ca_topic_score_gemma":0.002029365,"domain_scores_codex":[0.9994779,0.0003343206,0.00003107004,0.00005809145,0.00004588384,0.00005274171],"domain_scores_gemma":[0.9992142,0.0002463197,0.0002099415,0.00004853672,0.00003912485,0.0002418729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.969017,0.004692823,0.0009208847,0.0002287074,0.001079794,0.00002312788,0.0000342502,0.0004485411,0.003058401,0.00005312813,0.0006395527,0.01980367],"study_design_scores_gemma":[0.8267493,0.1651165,0.004232074,0.00003946403,0.00133499,0.00005927298,0.00002533146,0.0007587024,0.0007684006,0.000160756,0.0007412158,0.00001396309],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926042,0.004361263,0.0002917815,0.0004619126,0.0002773188,0.0006853466,0.0004237318,0.00004437041,0.0008500769],"genre_scores_gemma":[0.992008,0.002976312,0.0008936708,0.0007247285,0.0003952459,0.0008696443,0.0007243585,0.00001497979,0.001393182],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002567432,"threshold_uncertainty_score":0.009727657,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1158062761522462,"score_gpt":0.47668609962928,"score_spread":0.3608798234770338,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}